z-logo
open-access-imgOpen Access
Pharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian population
Author(s) -
Ritu Kumari,
Ram Lakhan,
Ravindra Kumar Garg,
Jayantee Kalita,
U. K. Misra,
Balraj Mittal
Publication year - 2011
Publication title -
indian journal of human genetics
Language(s) - English
Resource type - Journals
eISSN - 0971-6866
pISSN - 1998-362X
DOI - 10.4103/0971-6866.80357
Subject(s) - pharmacogenetics , genotyping , pharmacogenomics , genotype , odds ratio , cyp2c9 , epilepsy , drug , medicine , pharmacology , biology , polymorphism (computer science) , genetics , gene , psychiatry
In epilepsy, in spite of the best possible medications and treatment protocols, approximately one-third of the patients do not respond adequately to anti-epileptic drugs. Such interindividual variations in drug response are believed to result from genetic variations in candidate genes belonging to multiple pathways.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom